10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/31/2024
8:27 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:29 AM | Aerovate Therapeutics (Subject)
| Form 425 | |
10/17/2024
3:59 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/10/2024
4:04 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:31 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
7:00 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
5:00 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
06/20/2024
4:56 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:35 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:44 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:00 PM | Aerovate Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
7:29 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:57 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:39 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:59 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
3:16 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024
4:23 PM | Aerovate Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:18 AM | Aerovate Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:19 AM | Aerovate Therapeutics (Filer)
| Form DEFA14A | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Do this if you missed cheap Bitcoin (Ad) Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years?
If so, you don't want to miss this...
Because a new blockchain is taking the world by storm…
It’s seeing rapid adoption amongst crypto fans…
And just now starting to break into the mainstream.
While I cannot promise future returns or against losses…
This might not just be another chance at Bitcoin-like gains…
It could be EVEN bigger.
But this market is moving fast…
So if you want a shot at getting in on what could be the ground floor Click Here for Details. |
04/16/2024
3:25 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:42 PM | Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:18 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
6:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:31 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
8:22 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:15 PM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:12 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:35 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:37 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
2:28 PM | Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:34 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
6:09 PM | Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
| Form SC 13D/A | |
02/20/2024
5:38 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
3:28 PM | Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:45 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:29 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:11 PM | Aerovate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
6:59 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Do this if you missed cheap Bitcoin (Ad) Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years?
If so, you don't want to miss this...
Because a new blockchain is taking the world by storm…
It’s seeing rapid adoption amongst crypto fans…
And just now starting to break into the mainstream.
While I cannot promise future returns or against losses…
This might not just be another chance at Bitcoin-like gains…
It could be EVEN bigger.
But this market is moving fast…
So if you want a shot at getting in on what could be the ground floor Click Here for Details. |
12/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:50 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:24 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:04 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
